Imagin Medical (CNSX:IME) Director John Francis Vacha purchased 42,000 shares of the firm’s stock in a transaction that occurred on Monday, April 16th. The shares were bought at an average cost of C$0.24 per share, with a total value of C$10,080.00.
CNSX:IME traded up C$0.01 during trading hours on Monday, hitting C$0.30. The company’s stock had a trading volume of 1,270,000 shares. Imagin Medical has a 52-week low of C$0.05 and a 52-week high of C$0.44.
About Imagin Medical
Imagin Medical Inc is a Canada-based medical imaging company. The Company is engaged in the development of i/Blue imaging system for the early detection of cancer through the use of endoscopes. The Company focuses on managing the way physicians detect cancer. The Company’s initial target market is bladder cancer.
Receive News & Ratings for Imagin Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imagin Medical and related companies with MarketBeat.com's FREE daily email newsletter.